Overview
Torleif Hard practices practicing medicine in Uppsala, Sweden.
Their clinical expertise encompasses Alzheimer's Disease, Dementia, Parkinson's Disease, and Movement Disorders.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Torleif Hard
Is Torleif Hard a top-rated expert for Alzheimer's Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Torleif Hard is classified as an Experienced expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Torleif Hard participate in research or clinical trials?
Yes. Torleif Hard has published 21 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Torleif Hard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alzheimer's DiseaseHard isExperienced. Learn about Alzheimer's Disease.
- DementiaHard isExperienced. Learn about Dementia.
- Movement DisordersHard isExperienced. Learn about Movement Disorders.
- Parkinson's DiseaseHard isExperienced. Learn about Parkinson's Disease.